TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE USING CHOLESTEROL LOWERING AGENTS AND H3 RECEPTOR ANTAGONIST/INVERSE AGONIST.

摘要

This invention provides for method for the treatment, prevention or ameliorating the symptoms of nonalcoholic fatty liver disease (NAFLD) in a mammal in need thereof comprising the step of administering an effective amount of a composition comprising a therapeutic combination of at least one cholesterol lowering agent and/or at least one H3 antagonist/inverse agonist.